ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351909. A total of 3 filers reported holding ALEXION PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,741,000 | -32.4% | 66,300 | -19.4% | 0.01% | -35.7% |
| Q1 2016 | $11,458,000 | +13.5% | 82,300 | +55.6% | 0.01% | +27.3% |
| Q4 2015 | $10,091,000 | +31.2% | 52,900 | +7.5% | 0.01% | +57.1% |
| Q3 2015 | $7,694,000 | -48.3% | 49,200 | -40.2% | 0.01% | -46.2% |
| Q2 2015 | $14,877,000 | +28.9% | 82,300 | +23.6% | 0.01% | +18.2% |
| Q1 2015 | $11,542,000 | -46.3% | 66,600 | -42.6% | 0.01% | -47.6% |
| Q4 2014 | $21,482,000 | +32.9% | 116,100 | +19.1% | 0.02% | +23.5% |
| Q3 2014 | $16,167,000 | +31.1% | 97,500 | +23.6% | 0.02% | +21.4% |
| Q2 2014 | $12,328,000 | -34.5% | 78,900 | -36.2% | 0.01% | -36.4% |
| Q1 2014 | $18,818,000 | -43.7% | 123,700 | -50.8% | 0.02% | -50.0% |
| Q4 2013 | $33,424,000 | +35.9% | 251,200 | +18.6% | 0.04% | +18.9% |
| Q3 2013 | $24,602,000 | +102.1% | 211,800 | +60.5% | 0.04% | +76.2% |
| Q2 2013 | $12,176,000 | – | 132,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|